Akihiro Watari
Impact in
- Neurology top 5%
- Barrier Structure and Function Studies
- Neurological Disease Mechanisms and Treatments
- Drug Discovery top 10%
Papers in
- Neurology 23
- Barrier Structure and Function Studies 23
- Neurological Disease Mechanisms and Treatments 5
-
- Connexins and lens biology 4
- Glycosylation and Glycoproteins Research 3
- Ubiquitin and proteasome pathways 3
- Gut microbiota and health 3
- Co-authors
- Masuo Kondoh (33 shared papers)Kiyohito Yagi (32 shared papers)Masuo Yutsudo (7 shared papers)Katsuhiro Isoda (1 shared paper)Masakazu Kobayashi (1 shared paper)Makoto Tamesada (1 shared paper)Masaya Kawase (1 shared paper)Ayano Itoh (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (6 papers)The FASEB Journal (5 papers)Biochemical and Biophysical Research Communications (4 papers)Oncogene (2 papers)Biological and Pharmaceutical Bulletin (2 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Akihiro Watari
42 papers receiving 966 citations
Peers
Comparison fields: 5 of 111
- Neurology 279
- Drug Discovery 2
- Biochemistry 56
- Pharmacology 75
- Pharmaceutical Science 47
Countries citing papers authored by Akihiro Watari
This map shows the geographic impact of Akihiro Watari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Watari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Watari more than expected).
Fields of papers citing papers by Akihiro Watari
This network shows the impact of papers produced by Akihiro Watari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Watari. The network helps show where Akihiro Watari may publish in the future.
Co-authors
The 25 scholars most cited alongside Akihiro Watari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 197 | |
| 2 | 2013 | 61 | |
| 3 | 2018 | 50 | |
| 4 | 2017 | 49 | |
| 5 | 2003 | 47 | |
| 6 | 2015 | 42 | |
| 7 | 2003 | 36 | |
| 8 | 2017 | 34 | |
| 9 | 2015 | 34 | |
| 10 | 2006 | 34 | |
| 11 | 2017 | 33 | |
| 12 | 2010 | 28 | |
| 13 | 2014 | 27 | |
| 14 | 2016 | 26 | |
| 15 | 2014 | 26 | |
| 16 | 2015 | 24 | |
| 17 | Hepatotoxicity of sub-nanosized platinum particles in mice. | 2013 | 22 |
| 18 | 2017 | 18 | |
| 19 | 2017 | 17 | |
| 20 | 2015 | 16 |
About Akihiro Watari
Akihiro Watari is a scholar working on Neurology, Molecular Biology, Oncology, Cell Biology and Immunology, having authored 42 papers that have together received 978 indexed citations. Recurring topics across this work include Barrier Structure and Function Studies (23 papers), Drug Transport and Resistance Mechanisms (5 papers), Neurological Disease Mechanisms and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Connexins and lens biology (4 papers), Glycosylation and Glycoproteins Research (3 papers), Ubiquitin and proteasome pathways (3 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Neurology (279 citations), Drug Discovery (2 citations), Biochemistry (56 citations), Pharmacology (75 citations) and Pharmaceutical Science (47 citations). Akihiro Watari has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Masuo Kondoh, Kiyohito Yagi, Masuo Yutsudo, Katsuhiro Isoda, Masakazu Kobayashi, Makoto Tamesada, Masaya Kawase, Ayano Itoh, Xiangru Li and Hidehiko Suzuki. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, The FASEB Journal, Biochemical and Biophysical Research Communications, Oncogene and Biological and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.